New Application Deadline: Monday, April 1, 2024 | 5:00 pm EST Request for Applications The milestone driven Accelerated Translational Incubator Pilot (ATIP) Program provides awards ranging…
Johns Hopkins Medicine is committed to making the experience of being a research participant as positive as possible. Every six months, the ICTR randomly selects…
What Works for Cancer Immunotherapy May Also Work for Alzheimer’s Disease In experiments with lab-grown brain cells and mouse models, scientists at Johns Hopkins Medicine…
Academic Program Administrator Job Req ID: 112811 We are seeking an Academic Program Administrator who will provide program support for Trainees, Scholars, and Program Faculty. Administration and…
Designed for faculty and staff engaged in clinical care delivery or its management Johns Hopkins recognizes that a learning health system mindset is central to…
Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called…
Application Deadline: Monday, April 8, 2024 | 11:59 pm Apply View Request for Applications For questions, please contact Patrick Shea at [email protected].
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel…
The Research Navigators regularly receive questions covering a wide range of topics about conducting research studies at Johns Hopkins. It is not uncommon for multiple…
Findings from recent investigation suggest physicians can feel confident prescribing treatment based on results from patient-reported, self-administered tests In a study involving nearly 1,000 patients…
